Baudax Bio Inc
OTC:BXRXQ
Baudax Bio Inc
OTC:BXRXQ
Price:
0.0001
USD
Market Closed
Market Cap:
$44
Cash Flow Statement
Cash Flow Statement
Baudax Bio Inc
Baudax Bio Inc
Currency: USD
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(78)
|
(51)
|
(42)
|
(33)
|
(69)
|
(88)
|
(66)
|
(76)
|
(53)
|
(38)
|
(66)
|
(20)
|
(16)
|
(8)
|
(20)
|
(59)
|
(35)
|
(34)
|
(7)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
0
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
3
|
2
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
4
|
6
|
5
|
5
|
7
|
7
|
9
|
9
|
9
|
8
|
3
|
5
|
(0)
|
(1)
|
2
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
(0)
|
(8)
|
(8)
|
(9)
|
36
|
58
|
27
|
29
|
2
|
(14)
|
17
|
(29)
|
(35)
|
(38)
|
(19)
|
29
|
14
|
16
|
(11)
|
|
| Change in Working Capital |
4
|
(10)
|
(5)
|
(9)
|
(10)
|
1
|
0
|
1
|
(4)
|
(2)
|
(5)
|
(3)
|
1
|
(1)
|
(0)
|
0
|
(1)
|
0
|
4
|
|
| Cash from Operating Activities |
(74)
N/A
|
(68)
+9%
|
(55)
+19%
|
(50)
+9%
|
(42)
+16%
|
(29)
+32%
|
(37)
-31%
|
(44)
-18%
|
(52)
-17%
|
(51)
+2%
|
(51)
-1%
|
(49)
+4%
|
(48)
+2%
|
(45)
+6%
|
(37)
+19%
|
(28)
+24%
|
(20)
+30%
|
(16)
+19%
|
(14)
+9%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(4)
|
(3)
|
(3)
|
(1)
|
(1)
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(12)
|
(10)
|
0
|
7
|
12
|
10
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(4)
N/A
|
(3)
+13%
|
(3)
+8%
|
(1)
+51%
|
(1)
+24%
|
0
N/A
|
0
N/A
|
(1)
N/A
|
(8)
-1 183%
|
(13)
-57%
|
(11)
+18%
|
(0)
+98%
|
7
N/A
|
12
+63%
|
10
-17%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
-14%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
27
|
29
|
29
|
29
|
15
|
12
|
12
|
12
|
9
|
9
|
14
|
19
|
14
|
18
|
13
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
10
|
10
|
10
|
10
|
(0)
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(5)
|
(5)
|
|
| Other |
78
|
71
|
58
|
69
|
54
|
28
|
23
|
18
|
28
|
37
|
40
|
23
|
13
|
4
|
4
|
0
|
1
|
(1)
|
1
|
|
| Cash from Financing Activities |
78
N/A
|
71
-9%
|
58
-18%
|
69
+19%
|
81
+17%
|
68
-17%
|
62
-8%
|
57
-8%
|
52
-9%
|
49
-6%
|
52
+5%
|
35
-33%
|
22
-38%
|
13
-39%
|
18
+34%
|
17
-2%
|
12
-31%
|
12
+0%
|
9
-25%
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
0
N/A
|
0
N/A
|
18
N/A
|
38
+116%
|
39
+3%
|
25
-38%
|
13
-49%
|
(8)
N/A
|
(14)
-84%
|
(10)
+30%
|
(14)
-47%
|
(19)
-33%
|
(20)
-5%
|
(9)
+55%
|
(11)
-17%
|
(8)
+27%
|
(4)
+51%
|
(5)
-39%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(78)
N/A
|
(71)
+9%
|
(58)
+18%
|
(52)
+11%
|
(43)
+17%
|
(29)
+34%
|
(37)
-31%
|
(45)
-20%
|
(52)
-17%
|
(51)
+2%
|
(52)
-1%
|
(49)
+4%
|
(48)
+3%
|
(45)
+6%
|
(37)
+19%
|
(28)
+24%
|
(20)
+30%
|
(16)
+19%
|
(14)
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
